Effect of short-interval rituximab and high-dose corticosteroids on kidney function in systemic sclerosis: Long-term experience of a single centre.

Balazs OdlerCarina HebesbergerLukas HoeflechnerGudrun PregartnerPaul GressenbergerPhilipp JudSabine ZenzKathrin EllerAlexander R RosenkranzFlorentine Moazedi-Fuerst

Published in: International journal of clinical practice (2021)

A regular, high-dose CS given contemporary to RTX seems to be a safe option for kidney function in patients with SSc. Our findings provide additional knowledge in risk evaluation and planning of individualised therapies or designing clinical studies using RTX.

Keyphrases

high dose
systemic sclerosis
interstitial lung disease
stem cell transplantation
low dose
healthcare
diffuse large b cell lymphoma
hodgkin lymphoma